David N. Gordon

Insider Reports History

Location
Malvern, PA
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David N. Gordon:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aclaris Therapeutics, Inc. Chief Medical Officer Common Stock 147,447 $154,819 $1.05 13 Jul 2021 Direct

Insider Reports Filed by David N. Gordon

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACRS Aclaris Therapeutics, Inc. 13 Jul 2021 1 -$44,675 4 Chief Medical Officer 14 Jul 2021, 17:32
ACRS Aclaris Therapeutics, Inc. 02 Jul 2021 2 $0 4 Chief Medical Officer 07 Jul 2021, 18:03
ACRS Aclaris Therapeutics, Inc. 01 Jun 2021 6 -$1,142,375 4 Chief Medical Officer 02 Jun 2021, 21:49